Harvard Bioscience, Inc.
Harvard Bioscience, Inc. scores highest on Nitro (88) and lowest on Price (14). Its PosiPenta is 43.40 out of 100, around the middle of similar companies.
On the Penta Grid this week, Harvard Bioscience, Inc. is Grid #425 of 837 in the Healthcare sector in United States, and Grid #2,554 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Harvard Bioscience, Inc. | 43.40 | 14 | 58 | 88 | 18 | 40 |
| SCYNEXIS, Inc. | 41.29 | 45 | 28 | 30 | 65 | 38 |
| Dogwood Therapeutics, Inc. | 52.52 | 91 | 44 | 15 | 66 | 47 |
| Elutia Inc. | 40.08 | 26 | 34 | 59 | 38 | 44 |
| Nephros, Inc. | 56.23 | 47 | 63 | 56 | 71 | 44 |
| Instil Bio, Inc. | 31.50 | 47 | 10 | 23 | 42 | 35 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.50 |
| P/B ratio | 4.96 |
EEarnings
| Trailing EPS | ₹-218.79 |
| Forward EPS | ₹61.09 |
NNitro
| Price | 766.24 |
| 52-week high | 890.32 |
| 52-week low | 359.92 |
| Fall from 52-week high | 13.9% |
TTorque
| Return on equity (ROE) | -89.95% |
| Debt-to-equity | 5.96 |
AAnchor
| Beta (price swings) | 1.51 |
| Market cap | ₹348 Cr |
| Insider holding | 9.39% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Harvard Bioscience, Inc.'s PosiPenta score?
Harvard Bioscience, Inc.'s PosiPenta is 43.40 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Harvard Bioscience, Inc. stand on the Penta Grid?
On the Penta Grid this week, Harvard Bioscience, Inc. is Grid #425 of 837 in the Healthcare sector in United States, and Grid #2,554 of 4,000 in United States.
Which PosiPenta pillar is strongest for Harvard Bioscience, Inc.?
Nitro (momentum), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Harvard Bioscience, Inc.?
Price (valuation), with a score of 14 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.